Parexel International (ma) Corporation

Location

Massachusetts

Founded

1983-02-28

Website

https://www.parexel.com

Risk Signals

451 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Inter-Organizational Collaborations (133) Research Breakthroughs (117) Acquisition Announcements (106) New Product Release (80) Research and Development (76) Executive Leadership Changes (71) Market Trends (51) Business Growth Initiatives (50) Financial Reporting (41) Corporate Awards and Recognitions (41) Earnings Reports & Warnings (39) Recruitment Activities (33) Political and Economic Developments (33) Stock Market Events (29) Workforce Reductions (29) Legal Proceedings (25) Access and Affordability Initiatives (25) Business Agreements (25) Corporate Deals (24) Competitive Market Dynamics (23) Data Privacy Regulations (19) Equity Analysis & Ratings (16) Investment Strategies (14) Public Health Crisis Response (12) Investor Activism (12) Business Launches (12) Remote Work Policies (11) Corporate Relocations (10) Business Litigation (8) Ongoing Legal Investigations (8)

Recent Articles about Parexel International (ma) Corporation

Live alerts from global media, monitored by Business Radar

2024-12-09 (market.us)

Preclinical CRO Market on Track Growth For 7.5% CAGR By 2032

Global Preclinical CRO Market size is expected to be worth around US$ 10.5 Billion by 2032 from US$ 5.2 Billion in 2023

2024-09-19 (pharmaboardroom.com)

Top 10 CROs in 2024

Contract research organisations (CROs) have proven to be increasingly vital partners for the global biopharmaceutical industry guaranteeing efficient and compliant clinical trials that help to advance their candidates towards regulatory approvals. CROs have also demonstrated their ability to adapt